Trial intelligence / Profile preview

Phenylephrine ED90 for Postspinal Hypotension in Cesarean Section

NCT06151522Unknown

Sponsor
General Hospital of Ningxia Medical University
Start
Apr 2025
Primary completion
Jun 2025
Modality
Small Molecules
01

Overview

Randomised trial of phenylephrine in hypotension (2 arms), sponsored by General Hospital of Ningxia Medical University. Primary endpoint: 50% and 90% Effective Dose of Phenylephrine. Status: unknown.

02

Drugs

phenylephrine
03

Conditions

hypotension

Beyond the preview

Go deeper on NCT06151522.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06151522.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call